Abstract: The present disclosure provides novel variants of enzymes exhibiting serine protease activity; nucleic acid molecules encoding said proteases, vectors, host cells containing the nucleic acids and methods for preparation and producing such enzymes; compositions and complexes comprising at least one of the proteases; and methods for using such enzymes as a part of an immunoprotease, in particular for the treatment of cancer.
Type:
Grant
Filed:
September 21, 2012
Date of Patent:
December 27, 2016
Assignee:
PHARMED ARTIS GmbH
Inventors:
Stefan Barth, Sonja Schiffer, Grit Hehmann-Titt